combat

COMBAT - Updated biosecurity tool with 4 features

Read now
Cover Guilty Gilt

The Guilty Gilt Guide

Read now
PRRS Ctrl

PRRS Ctrl 2.0

Download for free
prrs-awards-placeholder

The 11th European PRRS Research Awards

Discover now
  • combat
    COMBAT - Updated biosecurity tool with 4 features
  • Cover Guilty Gilt
    The Guilty Gilt Guide
  • PRRS Ctrl
    PRRS Ctrl 2.0
  • prrs-awards-placeholder
    The 11th European PRRS Research Awards
September 2024
19
20
21
22
23
24
25
26
27
28
29
30
October 2024
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
November 2024
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
Episode 11 - IAV-S Mutation risk of a persistent yearround infection
Episodes

Episode 11 - IAV-S Mutation risk of a persistent yearround infection

“People coming into the herd should at least have a vaccination against influenza”

img-podcast
Episodes

Episode 15 - New gilts: Steering the health profile of herd replacements

“We plan a quarantine time of a minimum eight weeks and if we use MLV PRRS virus vaccines, we prefer around 12 weeks”

Tackle the problem by understanding the enemy
Asian PRRSpective | AS 2023

Asian PRRSpective 2023 – Tackle the problem by understanding the enemy

Dive into the highlights of the Asian PRRSpective 2023 event held in Osaka, Japan on November 7th, 2023, "Fighting Back - Using Evidence to Improve Disease Control". Join us as we explore key insights and strategies presented during this event.

Roundtable discussion  II
American PRRSpective | AM 2024

American PRRSpective 2024 – Roundtable discussion II

Dive into the dynamic discussions, insightful presentations, and vibrant exchanges that made this event unforgettable. Whether you're reliving your favorite moments or discovering new insights, these videos offer an immersive journey through the heart of our community's knowledge exchange.

bite-size-img
Bite size

How can I use tongues for PRRSv monitoring?

Meet the Expert Bite Size with Daniel Linhares.

26-image-prrs
Expertise article

Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection

Modified live virus (MLV) vaccines are commonly used to reduce the impact of porcine reproductive and respiratory syndrome (PRRS) but limited efficacy is achieved in field conditions. Here, we evaluated the impact of maternally-derived neutralizing antibodies (MDNAs) on vaccine efficacy after PRRS virus (PRRSV) challenge.

img
Expertise article

Emergence of a virulent porcine reproductive and respiratory syndrome virus (PRRSV) 1 strain in Lower Austria

In spring 2015, an outbreak of porcine reproductive and respiratory syndrome (PRRS) struck Lower Austria caused by a PRRS virus (PRRSV) strain spreading rapidly among both previously PRRSV negative and vaccinated pig herds. This case report describes the first well-documented emergence of the PRRSV strain responsible for this outbreak.

A PRRSV seronegative piglet-producing farm in Lower Austria encountered losses in foetuses and suckling piglets of up to 90 %; clinical signs in sows and nursery piglets included fever and reduced feed intake. Additionally, high percentages of repeat breeders and losses of up to 40 % in nursery piglets occurred. An infection with PRRSV was suggested by the detection of antibodies by enzyme linked immunosorbent assay and confirmed by quantitative real time PCR. The underlying PRRSV strain, termed AUT15-33, was isolated by passage on porcine alveolar macrophages, partially sequenced (ORF2-7) and grouped as PRRSV-1, subtype 1. In phylogenetic analysis of the genome region coding for the structural proteins, ORF2-7, AUT15-33 clustered with Belgian strains but identities were as low as 88 %. In contrast, analysis of ORF7 sequences revealed a close relationship to Croatian strains from 2012 with an identity of 94 – 95 %.